Bristol-Myers Squibb (BMY) Announces Additional CheckMate-032 Phase 1/2 Data in Previously Treated mUC Patients
Go back to Bristol-Myers Squibb (BMY) Announces Additional CheckMate-032 Phase 1/2 Data in Previously Treated mUC Patients| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 49.14 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $49.14 | 52 Week High | $77.12 | |||
| Open | $49.14 | 52 Week Low | $49.03 | |||
| Day High | $49.14 | P/E | 31.91 | |||
| Day Low | $49.14 | EPS | $1.54 | |||
| Volume | 470 | |||||
